Literature DB >> 18041412

Outcomes of pregnancies complicated by systemic lupus erythematosus (SLE).

Podjanee Phadungkiatwattana1, Pannee Sirivatanapa, Theera Tongsong.   

Abstract

OBJECTIVE: To assess the outcomes of pregnancies complicated by systemic lupus erythematosus (SLE) and evaluate the clinical course of the disease during pregnancy. MATERIAL AND
METHOD: The database of high-risk pregnancies between 1995 and 2006 was prospectively collected and searched for pregnancies with SLE. The medical records were reviewed
RESULTS: Sixty-eight pregnant women were identified during the period of the present study. Of 61 (89.7%) live births, 27 (39.7%) had preterm delivery and 20 (29.4%) had fetal growth restriction. Mean gestational age was 35.6 +/- 4.2 weeks. Mean neonatal birth weight was 2322 +/- 781 grams. There were seven (10.3%) perinatal deaths. Maternal SLE flares occurred in 20 (29.4%), seven in the first trimester, eight in the second trimester five in the third trimester, and none in the post partum period. Preeclampsia is the most common maternal complication (20.6%). There was a higher rate of flares if the pregnancy occurred while the disease was active. The predictor of poor pregnancies outcomes included flare-up of the disease, renal involvement, hypertension, and conception while the disease is active.
CONCLUSION: Active SLE prior to pregnancy is associated with a less favorable maternal and fetal outcome. Hypertension increased the risk of fetal loss and adverse outcome.

Entities:  

Mesh:

Year:  2007        PMID: 18041412

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  9 in total

Review 1.  Does the immune system induce labor? Lessons from preterm deliveries in women with autoimmune diseases.

Authors:  Norbert Gleicher
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

2.  Systemic lupus erythematosus pregnancies: the Sarawak experience and review of lupus pregnancies in Asia.

Authors:  C L Teh; J S Wong; N K N Ngeh; W L H Loh
Journal:  Rheumatol Int       Date:  2010-03-27       Impact factor: 2.631

Review 3.  A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis.

Authors:  Andrew Smyth; Guilherme H M Oliveira; Brian D Lahr; Kent R Bailey; Suzanne M Norby; Vesna D Garovic
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

4.  Evaluation of red blood cell distribution width-platelet ratio as a predictor of adverse pregnancy outcomes and disease severity in systemic lupus erythematosus.

Authors:  Jingjing Wang; Xiaodan He; Dongbin Jiang; Zhenbo Wang; Dalin Xu; Jianqiang Chen; Guanmin Gao; Xiaokang Liu
Journal:  Clin Rheumatol       Date:  2022-07-05       Impact factor: 3.650

Review 5.  Managing pregnancy in inflammatory rheumatological diseases.

Authors:  Varsha Jain; Caroline Gordon
Journal:  Arthritis Res Ther       Date:  2011-02-25       Impact factor: 5.156

6.  Pregnancy related complications in patients with systemic lupus erythematosus, an egyptian experience.

Authors:  S F Hendawy; D Abdel-Mohsen; S E Ebrahim; H Ewais; S H Moussa; D A Khattab; N A Mohamed; H E Samaha
Journal:  Clin Med Insights Reprod Health       Date:  2011-05-12

Review 7.  Preconception care: delivery strategies and packages for care.

Authors:  Zohra S Lassi; Sohni V Dean; Dania Mallick; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

Review 8.  Preconception care: screening and management of chronic disease and promoting psychological health.

Authors:  Zohra S Lassi; Ayesha M Imam; Sohni V Dean; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

9.  High-risk factors for adverse pregnancy outcomes in systemic lupus erythaematosus: a retrospective study of a Chinese population.

Authors:  Meng Jiang; Yanling Chang; You Wang; Qiong Fu; Sihan Lin; Jiayue Wu; Wen Di
Journal:  BMJ Open       Date:  2021-11-16       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.